rs4834308

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000506722.5(ANK2):​c.-39-17485A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.155 in 152,168 control chromosomes in the GnomAD database, including 2,312 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.15 ( 2312 hom., cov: 32)

Consequence

ANK2
ENST00000506722.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0540

Publications

8 publications found
Variant links:
Genes affected
ANK2 (HGNC:493): (ankyrin 2) This gene encodes a member of the ankyrin family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton. Ankyrins play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. The protein encoded by this gene is required for targeting and stability of Na/Ca exchanger 1 in cardiomyocytes. Mutations in this gene cause long QT syndrome 4 and cardiac arrhythmia syndrome. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Dec 2011]
ANK2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, ClinGen
  • Brugada syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, ClinGen
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
  • heart conduction disease
    Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
  • neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • cardiac arrhythmia, ankyrin-B-related
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.341 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK2NM_001386142.1 linkc.-39-17485A>C intron_variant Intron 1 of 44 NP_001373071.1
ANK2NM_001386143.1 linkc.-39-17485A>C intron_variant Intron 1 of 47 NP_001373072.1
ANK2NM_001386186.2 linkc.72+180753A>C intron_variant Intron 1 of 46 NP_001373115.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK2ENST00000506722.5 linkc.-39-17485A>C intron_variant Intron 1 of 46 1 ENSP00000421067.1 Q01484-5
ANK2ENST00000672209.1 linkc.-39-17485A>C intron_variant Intron 1 of 47 ENSP00000499982.1 A0A5F9ZH30
ANK2ENST00000673298.1 linkc.-39-17485A>C intron_variant Intron 1 of 46 ENSP00000500245.1 A0A5F9ZHE4

Frequencies

GnomAD3 genomes
AF:
0.155
AC:
23561
AN:
152050
Hom.:
2310
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0611
Gnomad AMI
AF:
0.130
Gnomad AMR
AF:
0.237
Gnomad ASJ
AF:
0.0769
Gnomad EAS
AF:
0.355
Gnomad SAS
AF:
0.204
Gnomad FIN
AF:
0.223
Gnomad MID
AF:
0.0854
Gnomad NFE
AF:
0.170
Gnomad OTH
AF:
0.121
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.155
AC:
23560
AN:
152168
Hom.:
2312
Cov.:
32
AF XY:
0.160
AC XY:
11867
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.0609
AC:
2531
AN:
41554
American (AMR)
AF:
0.237
AC:
3629
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0769
AC:
267
AN:
3470
East Asian (EAS)
AF:
0.354
AC:
1831
AN:
5168
South Asian (SAS)
AF:
0.204
AC:
985
AN:
4824
European-Finnish (FIN)
AF:
0.223
AC:
2358
AN:
10584
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.170
AC:
11561
AN:
67966
Other (OTH)
AF:
0.119
AC:
252
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
986
1972
2958
3944
4930
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
270
540
810
1080
1350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.160
Hom.:
4922
Bravo
AF:
0.155
Asia WGS
AF:
0.274
AC:
949
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
1.6
DANN
Benign
0.40
PhyloP100
-0.054
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4834308; hg19: chr4-113808126; API